R9-6-319. Carbapenem-resistant Pseudomonas aeruginosa

A. Case control measures: 1. A diagnosing health care provider or an administrator of a health care institution, either personally or through a representative, shall: a. Institute isolation precautions as necessary for a case with carbapenem-resistant Pseudomonas aeruginosa infection or colonization to prevent transmission; and b. If a case with carbapenem-resistant Pseudomonas aeruginosa infection or colonization is being transferred to another health care provider or health care institution or to a correctional facility, comply with R9-6-305. 2. An administrator of a correctional facility, either personally or through a representative, shall: a. Institute isolation precautions as necessary for a case with carbapenem-resistant Pseudomonas aeruginosa infection or colonization to prevent transmission; and b. If a case with carbapenem-resistant Pseudomonas aeruginosa infection or colonization is being transferred to another correctional facility or to a health care institution, comply with R9-6-305. 3. A local health agency, in consultation with the Department, shall ensure that: a. A case with carbapenem-resistant Pseudomonas aeruginosa infection or colonization is isolated as necessary to prevent transmission; and b. An isolate or a specimen, as available, from each case with carbapenem-resistant Pseudomonas aeruginosa infection or colonization is submitted to the Arizona State Laboratory. B. Outbreak control measures: A local health agency shall: 1. Conduct an epidemiologic investigation for each outbreak or suspected outbreak of carbapenem-resistant Pseudomonas aeruginosa; and 2. For each outbreak or suspected outbreak of carbapenem-resistant Pseudomonas aeruginosa, submit to the Department the information required under R9-6-206(E).